GILD FDA TODAY The Street " GILD A+ Rating and BUY Rating" link
Gilead Sciences Inc Stock Buy Recommendation Reiterated (GILD)
By TheStreet Wire 09/14/12 - 11:00 AM EDT
Find out if (GILD) is in Cramer's Portfolio.
NEW YORK (TheStreet) -- Gilead (Nasdaq:GILD) has been reiterated by TheStreet Ratings as a buy with a ratings score of A- . The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, attractive valuation levels, good cash flow from operations and expanding profit margins.